IS8416A - Aðferð við framleiðslu á CCR-2 mótlyfi - Google Patents

Aðferð við framleiðslu á CCR-2 mótlyfi

Info

Publication number
IS8416A
IS8416A IS8416A IS8416A IS8416A IS 8416 A IS8416 A IS 8416A IS 8416 A IS8416 A IS 8416A IS 8416 A IS8416 A IS 8416A IS 8416 A IS8416 A IS 8416A
Authority
IS
Iceland
Prior art keywords
ccr
antagonist
production
Prior art date
Application number
IS8416A
Other languages
English (en)
Inventor
Cai Dongwei
Fleitz Fred
Ge Min
Hoerrner Scott
Javadi Gary
Jensen Mark
Larsen Robert
Li Wenjie
Nelson Dorian
Szumigala Elizabeth
Yang Lihu
Zhou Changyou
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of IS8416A publication Critical patent/IS8416A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS8416A 2003-10-27 2006-04-12 Aðferð við framleiðslu á CCR-2 mótlyfi IS8416A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51475403P 2003-10-27 2003-10-27
PCT/US2004/035294 WO2005044795A1 (en) 2003-10-27 2004-10-25 Process for the preparation of ccr-2 antagonist

Publications (1)

Publication Number Publication Date
IS8416A true IS8416A (is) 2006-04-12

Family

ID=34572776

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8416A IS8416A (is) 2003-10-27 2006-04-12 Aðferð við framleiðslu á CCR-2 mótlyfi

Country Status (11)

Country Link
US (1) US7361765B2 (is)
EP (1) EP1682500A1 (is)
JP (1) JP4551405B2 (is)
CN (1) CN101160286B (is)
AR (1) AR045875A1 (is)
AU (1) AU2004287810B2 (is)
BR (1) BRPI0415862A (is)
CA (1) CA2543250C (is)
IS (1) IS8416A (is)
TW (1) TWI294426B (is)
WO (1) WO2005044795A1 (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1565436B1 (en) 2002-11-27 2012-04-25 Incyte Corporation 3-aminopyrrolidine derivatives as modulators of chemokine receptors
CN1826334A (zh) * 2003-03-18 2006-08-30 麦克公司 趋化因子受体活性的四氢吡喃基环戊基杂环酰胺调节剂
MXPA06004647A (es) * 2003-10-27 2006-06-27 Merck & Co Inc Sal antagonista de ccr-2.
KR20080052683A (ko) 2003-12-18 2008-06-11 인사이트 코포레이션 케모킨 수용체의 조절제로서의3-사이클로알킬아미노피롤리딘 유도체
BRPI0510665A (pt) 2004-05-11 2007-12-04 Incyte Corp 3-(4-heteroarilcicloexilamino) ciclopentano-carboxiamidas como moduladores de receptores de quimiocinas
WO2012125663A2 (en) * 2011-03-17 2012-09-20 Merck Sharp & Dohme Corp. Cyclohexane substituted amino cyclopentane derivatives as useful ccr2 antagonists
US8822460B2 (en) * 2012-04-06 2014-09-02 Janssen Pharmaceutica Nv Fused cyclopentyl antagonists of CCR2
CN104418769A (zh) * 2013-09-03 2015-03-18 苏州安尼康药物研发有限公司 一种化合物及其制备方法
US20180072945A1 (en) 2015-04-27 2018-03-15 Konica Minolta, Inc. Material for organic electroluminescent elements, organic electroluminescent element, display device and lighting device
DK3297438T3 (da) 2015-05-21 2022-01-17 Chemocentryx Inc Ccr2-modulatorer
CN105968055B (zh) * 2016-07-26 2018-08-28 中国科学院长春应用化学研究所 一种芳基嘧啶及其衍生物的制备方法
CA3293051A1 (en) 2017-09-25 2026-03-02 Chemocentryx, Inc. Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitor
CN112105353B (zh) 2018-01-08 2024-04-19 凯莫森特里克斯股份有限公司 Ccr2拮抗剂治疗实体瘤的方法
US20190269664A1 (en) 2018-01-08 2019-09-05 Chemocentryx, Inc. Methods of treating solid tumors with ccr2 antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09291034A (ja) * 1996-02-27 1997-11-11 Yoshitomi Pharmaceut Ind Ltd 縮合ピリジン化合物およびその医薬としての用途
EP1318811B1 (en) * 2000-08-17 2006-08-30 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
JP2004529943A (ja) * 2001-05-15 2004-09-30 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 殺菌・殺カビ剤としてのピリジニル縮合二環式アミド
EP1501507B1 (en) 2002-04-29 2008-05-28 Merck & Co., Inc. Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
MXPA06004647A (es) * 2003-10-27 2006-06-27 Merck & Co Inc Sal antagonista de ccr-2.

Also Published As

Publication number Publication date
JP4551405B2 (ja) 2010-09-29
TWI294426B (en) 2008-03-11
TW200530233A (en) 2005-09-16
BRPI0415862A (pt) 2007-01-09
CA2543250A1 (en) 2005-05-19
WO2005044795A1 (en) 2005-05-19
WO2005044795A8 (en) 2006-06-22
AU2004287810B2 (en) 2011-01-06
CA2543250C (en) 2011-03-29
CN101160286A (zh) 2008-04-09
CN101160286B (zh) 2012-07-04
US7361765B2 (en) 2008-04-22
US20070135475A1 (en) 2007-06-14
AR045875A1 (es) 2005-11-16
EP1682500A1 (en) 2006-07-26
JP2007509944A (ja) 2007-04-19
AU2004287810A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
PT1398327E (pt) Método de produção de derivados de hidroxialquil-amido
CY2015015I1 (el) Παραγωγη τιακουμυκινης
NO20053796D0 (no) Process for the production of particles
DE602005026757D1 (de) Tonerherstellungsmethode
IS8416A (is) Aðferð við framleiðslu á CCR-2 mótlyfi
HRP20150163T1 (xx) Postupak za proizvodnju n-supstituiranih 2-cijanopirolidina
IL175148A0 (en) Method for the production of fluoromethyl-substituted heterocycles
PL394821A1 (pl) Sposób wytwarzania kombrestatyn
DE602004003115D1 (de) Tonerherstellungsverfahren
ATE465155T1 (de) Verfahrensherstellung von ethern
IS8333A (is) Aðferð við framleiðslu á THIP
DE602004005971D1 (de) Aquakulturverfahren
DE60326321D1 (de) Herstellungsverfahren von Farbstoffen
NO20035626D0 (no) Metode
IS2894B (is) Framleiðsla sómatóstatínpeptíða
DE602004024308D1 (de) Immunchromatographisches verfahren
NO20035401D0 (no) Metode
NO20054532D0 (no) Fremgangsmater for a forhindre glukonoylering av proteiner
ITRE20030116A1 (it) Metodo per la fabbricazione di piastrelle dotate di
NO20035692D0 (no) Produksjonsmetode
ATE340161T1 (de) Herstellung von quinapril hydrochlorid
ITFI20030052A1 (it) Metodo per la produzione di argille organofile
ITAN20030003A1 (it) Metodo per la realizzazione di caldaie per la produzione
GEU20041064U (en) Method for production of Matsoni
EE00391U1 (et) Ujulesta valmistamismeetod